INTERCEPT PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 305 MADISON AVENUE, MORRISTOWN, NJ 07960
官方登记数据
0位关注者
2002成立于
关于 INTERCEPT PHARMACEUTICALS, INC.
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.
Source: Wikipedia
行业Pharmaceutical Preparations
总部305 MADISON AVENUE, MORRISTOWN, NJ 07960
成立2002
法律形式C Corporation
状态营业中
专利253 项专利
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USEUS20260000682A1 · 2026
METHODS FOR AMELIORATING COGNITIVE IMPAIRMENT USING BILE ACID DERIVATIVESUS2025375459A1 · 2025
关键数据
法律信息
| 法定名称 | INTERCEPT PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1270073在 SEC EDGAR 上查看 ↗ |
| EIN | 22-3868459 |
| 行业代码(SIC) | 2834 |
| 注册地址 | 305 MADISON AVENUE, MORRISTOWN, NJ 07960 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026